Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Oil up 4% on Week in Volatile, Omicron-Impacted Trade

Published 12/23/2021, 02:01 PM
Updated 12/23/2021, 03:06 PM
© Reuters.

By Barani Krishnan

Investing.com - Oil prices jumped more than 4% on the week, rebounding from last week’s slump, as energy markets were caught in a wave of year-end volatility worsened by Covid’s Omicron variant.

West Texas Intermediate, the benchmark for U.S. crude, settled Thursday's trade up $1.03, or 1.4%, at $73.79 per barrel. That put WTI up 4.1% for the week, versus a 1.1% decline last week and a 8.2% gain the week before that.

London-traded Brent, the global benchmark for oil, settled up $1.56, or 2.1%, at $76.85 a barrel. For the week, Brent showed a gain of 4.5%, just like WTI, and following a pattern of volatility similar to the U.S. crude benchmark in previous weeks.

Thursday is the last trading day of this week, with U.S. markets closed on Friday in observation of Saturday’s Christmas holiday.

“It’s a tug-of-war till the end between the bulls and bears, and the bulls are winning now as the fears over the Omicron are waning,” said John Kildufff, founding partner at New York-based energy hedge fund Again Capital.

Oil prices were down about 6% between Friday and Monday combined as markets reacted to news of the Omicron becoming the dominant strain of the coronavirus in most parts of the world, including the United States. 

Major U.S. cities, including New York, Los Angeles and Chicago, announced mass cutbacks in social activity earlier this week and introduced various new restrictions to deal with the Covid variant. President Joe Biden had also warned that Americans who do not get vaccinated for the virus faced “a winter of severe illness and death”.

Those cautions aside, a general spike in Covid infections, hospitalizations — and, in some countries, even deaths —  had triggered broad risk aversion.

Much of the bearish mood, however, dissipated in the past 48 hours as evidence increasingly showed the Omicron to be a less lethal form of Covid despite its fast-spreading ability. 

The US Food and Drug Administration’s emergency authorization on Thursday for Pfizer’s Paxlovid pill — the world’s first for Covid — also boosted risk appetite.

(Article published at 2:10pm ET, updated at 3:06pm ET).

 

Latest comments

Wall Street wants that 100$ barrel so badly
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.